Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma

The recent sorafenib versus radioembolization in advanced hepatocellular carcinoma (SARAH) and selective internal radiation therapy versus sorafenib in locally advanced hepatocellular carcinoma (SIRveNIB) trials showed no statistically significant difference in overall survival for randomization to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JCO Oncol Pract
Prif Awduron: Marqueen, Kathryn E., Kim, Edward, Ang, Celina, Mazumdar, Madhu, Buckstein, Michael, Ferket, Bart S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2021
Pynciau:
ORIGINAL CONTRIBUTIONS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258013/
https://ncbi.nlm.nih.gov/pubmed/33417490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.00443
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg